• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

GSK is a potential buyout candidate for Novartis

Quote








We have horrible leadership. Simple as that. From the very top all they way down to field leadership roles. Been this way for decades. It's a toxic system where leaders are promoted based on "sales". Where ability to lead and manage people is an afterthought. Where utilizing the ability to critically think is frowned upon. We have all seen territories go to winners circle where the rep wasn't in the territory for half the year. Once saw a rep go to winners circle after she spent close to a year on a special project in a third world country. While noble and admirable it makes a person wonder how and why the territory performed so well without the individual involved at all. It's a joke and our leadership refuses, actually is incapable of identifying talent. They fall back to "how many times have your tiered"? "Ohhhh, Wow, you've tired 3 times int he last six years. Your management material"! And the cycle continues. With any luck GSK will be bought. But buyer beware! The leaders you retain carry a systemic amount of toxicity that metastasize and corrode positive culture. You've been warned.
 




anonymous said:
I tend to agree with every part of this statement.
Click to expand...
I as well.......anybody who does not think GSK is profitable is suffering from rectal cranial inversion.....As they are diversified in vaccines, specialty, Oncology, respiratory......they are a cash generating machine! If Novartis purchases them, we will get a windfall to our stock.....I would say the UK government stands in the way....and in a BIG way.
 




anonymous said:
We have horrible leadership. Simple as that. From the very top all they way down to field leadership roles. Been this way for decades. It's a toxic system where leaders are promoted based on "sales". Where ability to lead and manage people is an afterthought. Where utilizing the ability to critically think is frowned upon. We have all seen territories go to winners circle where the rep wasn't in the territory for half the year. Once saw a rep go to winners circle after she spent close to a year on a special project in a third world country. While noble and admirable it makes a person wonder how and why the territory performed so well without the individual involved at all. It's a joke and our leadership refuses, actually is incapable of identifying talent. They fall back to "how many times have your tiered"? "Ohhhh, Wow, you've tired 3 times int he last six years. Your management material"! And the cycle continues. With any luck GSK will be bought. But buyer beware! The leaders you retain carry a systemic amount of toxicity that metastasize and corrode positive culture. You've been warned.
Click to expand...
I agree with the statement relative to leadership hiring practices.......they hired this person and obviously erred in the selection process........it all begins with Sales brother/sister!..........without sales.....nobody gets paid!
 




anonymous said:
I as well.......anybody who does not think GSK is profitable is suffering from rectal cranial inversion.....As they are diversified in vaccines, specialty, Oncology, respiratory......they are a cash generating machine! If Novartis purchases them, we will get a windfall to our stock.....I would say the UK government stands in the way....and in a BIG way.
Click to expand...
 








Look at the stock
For the past 25 years, nothing but down while most other majors have tripled . Wish it had growth cause there’s still a lot of good folks trying just maybe not in all the right positions
 




Emma's hitting the CEO mid-career mark. She has performed mediocre, but it has not moved into a growth oriented company. Her over-animated "exciting" quarterly videos are getting a bit long in the tooth. Made some deft R&D changes out of the gate, but momentum has petered out. Honestly, until the culture changes, the company cannot change. And changing culture is firing current leadership, not asking them if they have changed their culture and have them benchmark themselves. Geez, Hal stated inability to move the needle on culture change was his biggest frustration as his departing words to the entire R&D. That was pretty telling of what the future holds for GSK innovation. First in class is just simply not in the formula of GSK capability with this R&D leadership. They have have no experience with it, so they have no template of success to work from.
 




anonymous said:
Look at the stock
For the past 25 years, nothing but down while most other majors have tripled . Wish it had growth cause there’s still a lot of good folks trying just maybe not in all the right positions
Click to expand...

Watch Moderna get the RSV adult vaccine approved, while GSK makes more excuses for yet another failure.
 




















anonymous said:
https://www.beckershospitalreview.com/pharmacy/dosage-mistakes-delay-sanofi-gsk-vaccine-trial.html

So blaming Sanofi completely for the usual GSK failure, are ye? It was a joint venture that cost GSK dearly. Look at the stock charts — if you can get your head out of the sand long enough.
Click to expand...

Yes rookie, it was only SA’s fault! Gsk only supplied them with the adjuvant! SA formulated the other part of the vaccine, which was dosed too low. Gsk had zero to do with managing the trials. Go troll elsewhere.
 




anonymous said:
Yes rookie, it was only SA’s fault! Gsk only supplied them with the adjuvant! SA formulated the other part of the vaccine, which was dosed too low. Gsk had zero to do with managing the trials. Go troll elsewhere.
Click to expand...
So angry! You know I guess if I was at GSK I'd be angry too. Poor company used to be the envy of the industry to work for, trips to Hawaii with a guest for everyone, reduced to a place that now only has the stench of mediocracy, wokeness and corruption. The good people left your company log ago.
 




anonymous said:
So angry! You know I guess if I was at GSK I'd be angry too. Poor company used to be the envy of the industry to work for, trips to Hawaii with a guest for everyone, reduced to a place that now only has the stench of mediocracy, wokeness and corruption. The good people left your company log ago.
Click to expand...

Two days off and this is your best comeback? Your mom would be so embarrassed of you.
 








anonymous said:
Can we get back on topic? What are the chances of GSK selling off parts of the business. I’m looking to get out with a severance.
Click to expand...

Aren’t we all, brother?!

The stock price got a brief bump on news of the Zantac lawsuits being frivolous. But surprise surprise — it’s now lower than where the share price was when the news broke. The head in the sand crew can defend this dying company all they like, but it won’t change its inevitable destruction.
 








Top Bottom
Back
Quote